NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 73 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $102,060 | -78.9% | 56,700 | -75.1% | 0.00% | -63.6% |
| Q3 2022 | $483,000 | -8.2% | 228,000 | +16.6% | 0.01% | 0.0% |
| Q2 2022 | $526,000 | -38.3% | 195,500 | -0.5% | 0.01% | -21.4% |
| Q1 2022 | $853,000 | +49.6% | 196,500 | +78.6% | 0.01% | +40.0% |
| Q4 2021 | $570,000 | +104.3% | 110,000 | +141.8% | 0.01% | +100.0% |
| Q3 2021 | $279,000 | -21.2% | 45,500 | +30.0% | 0.01% | -16.7% |
| Q2 2021 | $354,000 | – | 35,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $30,663,000 | 4.08% |
| Ally Bridge Group (NY) LLC | 1,500,000 | $9,210,000 | 2.71% |
| AMAZON COM INC | 1,457,055 | $8,946,000 | 1.82% |
| Affinity Asset Advisors, LLC | 975,000 | $5,987,000 | 1.51% |
| Tikvah Management LLC | 708,540 | $4,350,436,000 | 1.18% |
| Perceptive Advisors | 8,911,151 | $54,714,000 | 0.80% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $12,280,000 | 0.76% |
| HILLMAN CO | 200,000 | $1,228,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,912,000 | 0.41% |
| RA Capital Management | 2,436,430 | $14,960,000 | 0.21% |